Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu
Education
  • 2018 Karadeniz Teknik University Faculty of Medicine Çocuk Romatolojisi
  • 2016 Pediatric Rheumatology International Trial Organisation (PRINTO),Pediatric Rheumatology, Pediatria II, Pediatria Rheumatologia, Malattie Rare, Gaslini, Genova, Italy / Fellowsip
  • 2014 Kanuni Sultan Süleyman Eğitim ve Araştırma Hospital Çocuk Sağlığı ve Hastalıkları
  • 2009 İstanbul University Cerrahpaşa Faculty of Medicine
Experience
  • 2021 Acıbadem Healthcare Services
  • 2018 - 2021 Ümraniye Eğitim ve Araştırma Hospital / Çocuk Romatoloji Uzman Doktor
  • 2015 - 2018 Karadeniz Teknik University / Çocuk Romatoloji Bilim Dalı / Çocuk Romatoloji Yandal Asistanı
  • 2014 - 2015 Şanlıurfa Çocuk Sağlığı ve Hastalıkları Hospital, Şanlıurfa / Çocuk Sağlığı ve Hastalıkları Uzmanı
  • 2011 - 2014 Kanuni Sultan Süleyman Eğitim ve Araştırma Hospital, İstanbul
  • 2009 - 2014 Çocuk Sağlığı ve Hastalıkları Asistanı
  • 2009 - 2011 Bakırköy Yenimahalle Kadın Doğum ve Çocuk Sağlığı ve Hastalıkları Hospital
Memberships
  • Türk Çocuk Romatoloji Association
  • Avrupa Çocuk Romatoloji Association
PUBLICATIONS
  • Drug survival of the infliximab biosimilar (CT- P13) in paediatric patients with non-infectious uveitis. Clin Exp Rheumatol. 2021 Feb 9. Sözeri B, Kardeş E, Salı E, Çakır D, Demir F.
  • Clinical course of COVID-19 in children with rheumatic disease under biologic therapy Clin Exp Rheumatol. 2021 Jan-Feb;39 Demir F, Ulu K, Çağlayan Ş, Coşkuner T, Sözeri B.
  • Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis. Rheumatol Int. 2021 Mar 18. doi: 10.1007/s00296-021-04833-3. Çakmak F, Çakan M, Demir F, Sönmez HE, Çakmak S, Demîrkan FG, Karadağ ŞG, Ayaz NA, Sözeri B.
  • Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases Clin Rheumatol. 2021 Jun;40(6):2327-2337. doi: 10.1007/Sİ0067-020-05492-8. Sözeri B, Demir F, Sönmez HE, Karadağ ŞG, Demirkol YK, Doğan ÖA, Doğanay HL, Ayaz NA.
  • Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey Eker Omeroglu R, Aktay Ayaz N; PeRA-Research Group. Rheumatol Int. 2021 Jan 16:1-8. doi: 10.1007/s00296-020-04776-l. Kavrul Kayaalp G, Sözeri B, Sönmez HE, Demir F, Cakan M, Oztürk K, Karadağ SG, Otar Yener G, Ozdel S, Bağlan E, Celikel E, Şahin N, Gezgin Yildirim D,
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""